Dr. Mary L. Gannon

M.D.,C.A.D.C. | Psychiatry | Addiction Medicine


  2625 Butterfield Rd, Suite 103 W, Oak Brook
     Illinois, 60523-1234
  630-981-4886    Maps & Directions
Dr. Mary L. Gannon is a Oak Brook, Illinois based psychiatrist who is specialized in Addiction Medicine. Her current practice location is 2625 Butterfield Rd, Suite 103 W, Oak Brook. Patients can reach her at 630-981-4886. Dr. Mary L. Gannon is M.D.,C.A.D.C. in Addiction Medicine and her NPI number (Unique professional ID assigned by NPPES) is 1235268541.
Dr. Mary L. Gannon focuses on the evaluation, diagnosis, and treatment of people who have one or more disorders related to addictions like illegal drugs, alcohol, and prescription medication and other substances.
Complete Profile:
Dr. Mary L. Gannon speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Mary L. Gannon
Specialization: Addiction Medicine
Gender:Female
Credentials: M.D.,C.A.D.C.
Practice Address:2625 Butterfield Rd, Suite 103 W, Oak Brook,
Illinois, 60523-1234
Phone:630-981-4886
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1235268541
NPI Enumeration Date: 04 Mar, 2007
NPI Last Update On: 17 May, 2011

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Mary L. Gannon
326 Grandview Ave,
Glen Ellyn, Illinois
Zip: 60137-5220
Phone Number: 630-981-4886
Patients can reach Dr. Mary L. Gannon at 2625 Butterfield Rd, Suite 103 W, Oak Brook, Illinois or can call to book an appointment on 630-981-4886.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.